| venlafaxine / Generic mfg. |
ChiCTR-TNRC-10001112: The study on clinical and biological characters of bipolar depression and the treatment scheme optimizing |
|
|
| Completed | 4 | 640 | | Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride | Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health; Guangzhou first people's hospital, The Tackling Key Problems of Guangzhou Scientific and Technological Project | bipolar depressive disorder | | | | |
2015-001639-19: Transcranial direct current stimulation and venlafaxine in the treatment of depression |
|
|
| Ongoing | 4 | 60 | Europe | Capsule, hard, Venlafaxin Mylan 75 mg | Národní ústav duševního zdraví, Agentura pro zdravotnický výzkum České republiky | Depressive disorder, Depression, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2006-004457-20: Evaluation de l\'action neuroréparatrice fonctionnelle et morphologique du traitement antidepresseur au cours de la rémission clinique dans la dépression recurrente. |
|
|
| Ongoing | 4 | 88 | Europe | Stablon, Effexor, Norset, Stablon, Effexor, Norset, Stablon, Effexor, Norset, Stablon, Effexor, Norset | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | Dépression récurrente | | | | |
| Ongoing | 4 | 50 | Europe | Paroxetine, Amitriptyline, Clomipramine, Imipramine, Nortriptyline, escitalopram, Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Duloxetine, venlafaxine, EU/1/04/296/002, Seroxat, Tryptizol, Anafranil, Imipramine, Nortrilen, Lexapro, Cipramil, prozac, Fevarin, Zoloft, Cymbalta, Efexor, Seroxat, Tryptizol, Anafranil, Imipramine, Nortrilen, Lexapro, Cipramil, prozac, Fevarin, Zoloft, Cymbalta, Efexor | Isala Klinieken | Pregnant women with psychiatric morbidity and an strong indication for using antidepressants | | | | |
2011-002727-18: The effects of switching antidepressants on endoxifen exposure |
|
|
| Ongoing | 4 | 13 | Europe | Tamoxifen, Paroxetine, Escitalopram, Venlafaxine, RVG 09592, RVG 14668, RVG 30494, RVG 31854, Nolvadex, Seroxat, Lexapro, Efexor, Nolvadex, Seroxat, Lexapro, Efexor | | Breast cancer | | | | |
ChiCTR-OPC-17011266: The Efficacy of Venlafaxine, Flunarizine and Valproic acid in the Prophylaxis of Vestibular Migraine |
|
|
| Completed | 4 | 75 | | venlafaxine ;flunarizine ;valproic acid | Qianfoshan Hospital of Shandong province; Qianfoshan Hospital of Shandong province, This study was supported by the Shandong Science & Technology development program of TCM (2013-195) and Shandong Science & Technology development program of medicine and health(2015WS0246) | Vestibular Migraine | | | | |
ChiCTR-OPC-15005947: The clinical response of Venlafaxine for patients with major depression disorder with LDQS and with DBHS:A case-control study |
|
|
| Not yet recruiting | 4 | 75 | | Venlafaxine ;Venlafaxine ;Nil | Tongde Hospital of Zhejiang Province; Tongde Hospital of Zhejiang Province, First-phase Research Fund for Young Medical Investigators of Zhejiang Province; National Natural Science Foundation of China | Major Depression Disorder | | | | |
2016-003325-41: PREemptive Pharmacogenomic testing for Preventing Adverse drug REactions (PREPARE) |
|
|
| Ongoing | 4 | 450 | Europe | Syrup, Tablet, Capsule, hard, Powder for injection, Capsule, Solution for injection, Concentrate for solution for infusion, Powder for solution for infusion, Codeine, Acenocoumarol, Amitriptyline, Aripiprazole, Atomoxetine, Atorvastatine, Azathioprine, Capecitabine, Carbamazepine, Citalopram, Clomipramine, Clopidogrel, Clozapine, Efavirenz, Escitalopram, Flecainide, Flucloxacillin, Fluorouracil, Haloperidol, Irinotecan, Mercaptopurine, Metoprolol, Oxycodone, Paroxetine, Phenprocoumon, Phenytoin, ORAP 1 mg Tabletten, Propafenone, Sertraline, Simvastatin, Tacrolimus, Tamoxifen, Tegafur, Tioguanine, Tramadol, Venlafaxine, Voriconazole, Zuclopenthixol, Ethinylestradiol, ORAP 4 mg Tabletten | Leiden University Medical Center, Leiden University Medical Center | Adverse drug reactions, Side-effects, Not possible to specify | | | | |
ChiCTR2100048442: Clinical study of venlafaxine hydrochloride combined with tandospirone citrate in the treatment of vascular depression with somatization symptoms |
|
|
| Completed | 4 | 136 | | Venlafaxine hydrochloride 75mg, once a day, if there are no adverse drug events, adjust to 150mg once a day in the second week. ;Venlafaxine hydrochloride 75mg, once a day, if there is no adverse drug event, adjust to 150mg once a day in the second week, and add tandospirone citrate 5mg once a day at the beginning of treatment 3 times, adjusted to 10mg in the second week, 3 times a day. | Union Hospital, Fujian Medical University; Union Hospital, Fujian Medical University, Sumitomo Pharmaceutical Co., Ltd | Vascular depression | | | | |
ChiCTR1900021496: A study for efficacy of venlafaxine add on in treatment of inflammatory bowel disease patients with depression/anxiety. |
|
|
| Not yet recruiting | 4 | 30 | | Take 75mg of venlafaxine once daily in week 1;After one week, take venlafaxine 150mg once daily for nine months ;Placebo | West China Hospital, Sichuan University; West China Hospital, Sichuan University, Clinical research incubation project foundation of West China Hospital,Sichuan University | inflammatory bowel disease | | | | |
| Recruiting | 4 | 30 | Europe | Venlafaxine | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate | 03/24 | 04/24 | | |
2021-006800-34: Phase IV interventional pharmacological study to identify the changes in neuroplasticity at the cellular, molecular and neural level that occur in patients with major depression following the introduction of drug therapy with venlafaxine. Studio interventistico farmacologico di fase IV per identificare i cambiamenti di neuroplasticità a livello cellulare, molecolare e neurale che si verificano nei pazienti con depressione maggiore in seguito all’introduzione della terapia farmacologica con venlafaxina. |
|
|
| Not yet recruiting | 4 | 30 | Europe | ZARELIS - 75 MG COMPRESSE A RILASCIO PROLUNGATO, [Venlafaxina], Prolonged-release tablet, ZARELIS - 75 MG COMPRESSE A RILASCIO PROLUNGATO 14 COMPRESSE IN BLISTER PVC/PCTFE/AL | FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, Fondazione Cariplo - Bando di ricerca 2019 “Ricerca sulla Sindrome ansioso-depressiva: prevenzione, diagnosi precoce e t | patients with major depression Pazienti affetti da depressione maggiore, Mental disorder Disturbo mentale, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT05023278: The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement |
|
|
| Recruiting | 4 | 100 | US | Venlafaxine 37.5 MG, SNRI analgesia, Placebo, control | University of California, San Francisco, Orthopedic Research and Education Foundation | Acute Pain, Chronic Pain, Knee Pain Chronic, Neuropathic Pain | 12/24 | 03/25 | | |
| Recruiting | 4 | 60 | RoW | Venlafaxine 75 MG, Gabapentin 400 mg | Mit Ghamr Oncology Center | Peripheral Neuropathy Due to Chemotherapy | 10/23 | 12/23 | | |
| Active, not recruiting | 4 | 700 | US | Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written Exposure Therapy | University of Washington, Stanford University, Boston University, Washington State University, Patient-Centered Outcomes Research Institute | PTSD | 08/24 | 12/25 | | |
NCT04977271: Mood Disorders in Head and Neck Cancer Patients |
|
|
| Not yet recruiting | 4 | 205 | US | Venlafaxine, Effexor | University of Alabama at Birmingham | Depressive Disorder, Head and Neck Cancer | 09/26 | 09/28 | | |
ACTRN12619001082190: Serotonin Noradrenaline Reuptake Inhibitors (SNRI) medications for the treatment of osteoarthritis pain (STOP) trial |
|
|
| Recruiting | 3/4 | 146 | | | Waitemata District Health Board, Health Research Council of New Zealand | Knee osteoarthritis | | | | |
2006-003658-47: Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder. |
|
|
| Ongoing | 3 | 180 | Europe | Milnacipran, Venlafaxine, IXEL 25 mg, IXEL 50 mg, EFFEXOR 25 mg, EFFEXOR 50 mg, IXEL 25 mg, IXEL 50 mg, EFFEXOR 25 mg, EFFEXOR 50 mg | Pierre Fabre Médicament - IRPF | Major Depressive Disorder | | | | |
VENUS, NCT05104918: Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities |
|
|
| Not yet recruiting | 3 | 500 | NA | Vortioxetine, VORSCOT tablets, Venlafaxine, Venlafexine | Scotmann Pharmaceuticals, Rawalpindi Medical College | Major Depressive Disorder | 04/22 | 06/22 | | |
INTENSIFY BD, NCT05973786: The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. |
|
|
| Recruiting | 3 | 418 | Europe | Escitalopram, ATC code: N06AB10, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04 | Dr. Inge Winter, Universität Münster | Bipolar Depression | 06/26 | 06/26 | | |
INTENSIFY, NCT05603104: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure |
|
|
| Not yet recruiting | 3 | 1254 | RoW | Clozapine, ATC code: N05AH02, Esketamine Nasal Product, ATC code: N06AB10, Escitalopram, Sertraline, ATC code: N06AB06, Venlafaxine, ATC code: N06AX16, Lithium, ATC code: N05AN01, Valproate acid, ATC code: N03AG01, Quetiapine, ATC code: N05AH04, Second-line Antidepressants, Second-line Antipsychotics, Ketamine Hydrochloride, N01AX03, Esketamine hydrochloride, N015X14 | Dr. Inge Winter, Universität Münster | Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression | 06/26 | 06/26 | | |
| Not yet recruiting | 3 | 260 | NA | Oxybutynin, Venlafaxine | Reinier de Graaf Groep | Breast Cancer, Hot Flash Due to Medication | 01/29 | 01/29 | | |
NCT04737967: The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy |
|
|
| Recruiting | 2/3 | 60 | RoW | Venlafaxine, Memantine | Mendel AI, Cairo University | Oncology Pain, Chemotherapy-induced Peripheral Neuropathy | 08/21 | 10/21 | | |
NCT04218123: Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes |
|
|
| Completed | 2/3 | 40 | US | Venlafaxine, Placebo oral tablet | Medical University of South Carolina, American Hearing Research Foundation, Cures Within Reach | Meniere Disease | 09/23 | 09/23 | | |
| Recruiting | 2/3 | 330 | US | Antidepressant, AD: aripiprazole, bupropion, duloxetine, escitalopram, mirtazapine, sertraline, venlafaxine, Enhanced Fear Avoidance Rehabilitation, EFAR | Ajay Wasan, MD, Msc, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Brigham and Women's Hospital, Mayo Clinic | Chronic Low Back Pain, Negative Affectivity | 12/25 | 04/26 | | |
| Not yet recruiting | 2 | 116 | | | University of Tasmania, University of Tasmania | Chronic pain, Knee osteoarthritis | | | | |
2009-014056-30: Reconnaissance des expressons faciales émotionnelles chez les patients présentant un épisode dépressif magnétique transcranienne répétée du cortex préfrontal dorsolatéral droit à basse fréquence et/ou venlafaxine |
|
|
| Ongoing | 2 | 60 | Europe | Effexor, Effexor | CHU Clermont-Ferrand | depression | | | | |
| Completed | 2 | 20 | US | Acetazolamide, Diamox, Eszopiclone, Lunesta, Placebo, Venlafaxine, Effexor | University of California, San Diego, American Thoracic Society | OSA, Obstructive Sleep Apnea | 01/22 | 01/22 | | |
NCT04539951: Pragmatic Trial of Obsessive-compulsive Disorder |
|
|
| Recruiting | 2 | 1600 | RoW | Sertraline 200 milligram(mg), Sertraline 300 milligram(mg), Fluvoxamine, Venlafaxine, Augment with Memantine, Augment with Aripiprazole | Shanghai Mental Health Center, The first specialized hospital of harbin, Guizhou Provincial People's Hospital, First Affiliated Hospital of Jinan University, West China Hospital, Suzhou Psychiatric Hospital, Nanjing Medical University, Wuhan Mental Health Centre, Seventh People's Hospital of Hangzhou, The First Affiliated Hospital of Kunming Medical College, General Hospital of Ningxia Medical University, The First Affiliated Hospital of Nanchang University, The Second Affiliated Hospital of Xinxiang Medical University | Obsessive-Compulsive Disorder | 06/24 | 12/24 | | |
| Recruiting | 2 | 92 | Europe | microbiotherapy (GynMDD), placebo | Centre Hospitalier Universitaire de Besancon, Fondation FondaMental, GYNOV | Depression, Depressive Disorder, Depressive Disorder, Major | 07/24 | 12/24 | | |
NCT05724849: Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer |
|
|
| Withdrawn | 2 | 64 | NA | Venlafaxine, Effexor, Placebo | Vanderbilt University Medical Center | Head and Neck Cancer, Depression | 08/26 | 08/26 | | |
NCT05884268: Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy |
|
|
| Not yet recruiting | 1/2 | 60 | NA | Venlafaxine, Placebo | Mansoura University | Laparoscopic Cholecystectomy | 01/24 | 01/24 | | |
NCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea |
|
|
| Not yet recruiting | 1 | 66 | NA | Atomoxetine 80mg combined with oxybutynin 5mg, Venlafaxine 37.5mg, Atomoxetine 80mg combined with trazodone 100mg, Placebo | China Medical University Hospital | Obstructive Sleep Apnea of Adult | 07/25 | 07/25 | | |
ChiCTR-ROC-17010393: Efficacy research of acupuncture combined with venlafaxine in treating depression based on DTI |
|
|
| Recruiting | N/A | 60 | | Nil | tongde hospital of zhejiang province; tongde hospital of zhejiang province, Science Technology Department of Zhejiang Province | Depression | | | | |
NCT00667121: Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline |
|
|
| Active, not recruiting | N/A | 85 | US | citalopram hydrobromide, escitalopram oxalate, gabapentin, sertraline hydrochloride, tamoxifen citrate, venlafaxine, molecular genetic technique, high performance liquid chromatography, laboratory biomarker analysis, pharmacological study, adjuvant therapy | Mayo Clinic, National Cancer Institute (NCI) | Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment | 05/14 | 12/24 | | |
ChiCTR-OCH-13003864: Herbal medicine for hospitalized patients with severe depressive episode: a retrospective controlled study. |
|
|
| Completed | N/A | 140 | | the herbal preparation Gui-Pi Decoction combined venlafaxine ;venlafaxine only | Tongde Hospital of Zhejiang Province; Tongde Hospital of Zhejiang Province, First-phase Research Fund for Young Medical Investigators of Zhejiang Province | Major depressive disorder (MDD) | | | | |
ChiCTR-OCH-13003718: Study of the effects of venlafaxine for the brain plasticity of patients with generalized anxiety disorder |
|
|
| Completed | N/A | 60 | | Venlafaxine Hydrochloride SR Capsule ;None | Shanghai Mental Health Center; None, Pfizer Investigator Initiated Research | generalized anxiety disorder | | | | |
ChiCTR-INR-16008971: Efficacy and safety of ketamine combined with antidepressants in major depression: a randomized controlled trial |
|
|
| Not yet recruiting | N/A | 40 | | single-dose i.v. ketamine (0.5mg/kg, 40 minutes)+ venlafaxine (150 mg/day, 4weeks) ;single-dose i.v. midazolam (0.045 mg/kg, 40 minutes) + venlafaxine (150 mg/day, 4weeks) | Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, Beijing Key Laboratory for mental disorders | depression disorder | | | | |
ChiCTR-IOR-17012419: A Clinical Study Program about Treatment of Migraine - Depression Syndrome by Jieyu Decoction |
|
|
| Recruiting | N/A | 100 | | Oral Jieyu therapy ;Venlafaxine capsules | Shanghai TCM-integrated Hospital; Shanghai TCM-integrated Hospital, Shanghai science and Technology Committee | Migraine - Depression Syndrome | | | | |
ChiCTR1900026704: The role of miR-34b/c dysregulation and clinical transformation in depression |
|
|
| Recruiting | N/A | 120 | | N/A ;venlafaxine treatment for depression group | Shanxi Medical University; The First Clinical Hospital of Shanxi Medical University, Youth Science Fund project | Mood Disorders, psychological and physiological disorders and psychosomatic diseases | | | | |
ChiCTR1900028259: Comparative study for the effects of venlafaxine and duloxetine in the treatment of chemotherapy-induced peripheral neuropathy |
|
|
| Not yet recruiting | N/A | 120 | | CIPN is treated with venlafaxine or duloxetine ;CIPN is treated with venlafaxine or duloxetine | The Second Affiliated Hospital of Fujian Medical University; The Second Affiliated Hospital of Fujian Medical University, Scientific research fund of the Second Affiliated Hospital of Fujian Medical University | cancer | | | | |
ChiCTR1800017626: A precision medicine study on the treatment of depression using Venlafaxine and Escitalopram |
|
|
| Recruiting | N/A | 4200 | | oral administration of Venlafaxine (75-225 mg/day) ;oral administration of Escitalopram (10-20 mg/day) | Zhejiang University; The First Affliated Hospital, Zhejiang University School of Medicine, National Key Research and Development Plan, Precision Medicine Research Key Special Project | Depression | | | | |
ChiCTR1800017848: Single i.v.-ketamine augmentation of newly initiated venlafaxine hydrochloride for treatment-resistant depression: a randomized controlled trial |
|
|
| Recruiting | N/A | 40 | | single-dose i.v. ketamine (0.5mg/kg, 40 minutes)+ venlafaxine (4 weeks, 75mg/day in the first week and 150mg/day in the other 3 weeks) ;single-dose i.v. midazolam (0.045mg/kg, 40 minutes)+ venlafaxine (4 weeks, 75mg/day in the first week and 150mg/day in the other 3 weeks) | Beijing Chaoyang Hospital; Beijing Chaoyang Hospital, Capital's Funds for Health Improvement and Research(CFH) | depression disorder | | | | |
ChiCTR2100049812: The effects of Zuojin Pill on the pharmacokinetics of venlafaxine in healthy volunteers |
|
|
| Completed | N/A | 308 | | Single dose of venlafaxine ;concomitant use of venlafaxine and zuojin pill | Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Municipal Health Committee | NA | | | | |
NCT03294525: Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders |
|
|
| Recruiting | N/A | 400 | RoW | Escitalopram Pill, Lexapro, Duloxetine, Cymbalta, Mirtazapine Pill, Remeron, Other Antidepressants | Peking University | Affective Disorder | 12/21 | 08/22 | | |
BATEP, NCT04396314: Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial |
|
|
| Not yet recruiting | N/A | 54 | NA | Basic Body Awareness Therapy, Psychological treatment | Universitat de Lleida, Francesc Rubí Carnacea | PostTraumatic Stress Disorder | 12/21 | 04/22 | | |
ChiCTR2000040228: Analysis of the effect of exercise-assisted therapy on improving mood disorders |
|
|
| Not yet recruiting | N/A | 200 | | Sports +Venlafaxine Hydrochloride + Oxazepam ;Venlafaxine Hydrochloride + Oxazepam | Tongji Medical College Huazhong University of Science and Technology; Tongji Medical College Huazhong University of Science and Technology, Huawei Terminal Co., Ltd. | depression | | | | |
| Recruiting | N/A | 1000 | | Antidepressants (sertraline, esitalopram, venlafaxine) ;None | Fudan University; The Second Xiangya Hospital of Central South University, Shanghai Municipal Science and Technology Major Project | Major depressive disorder | | | | |
NCT04664088: Acupuncture for Prophylaxis of Vestibular Migraine |
|
|
| Not yet recruiting | N/A | 72 | RoW | Acupuncture, Venlafaxine | First Affiliated Hospital of Jiaxing University | Vestibular Migraine | 06/23 | 12/23 | | |
NCT05952713: Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder |
|
|
| Completed | N/A | 73336 | Europe | Antidepressant, sertraline, citalopram, fluoxetine, paroxetine, escitalopram, reboxetine, venlafaxine, duloxetine, mirtazapine, vortioxetine, agomelatine, amitriptyline, imipramine | Mental Health Services in the Capital Region, Denmark, University of Copenhagen | Major Depressive Disorder | 07/23 | 07/23 | | |
NCT05931965: Combination Therapy of Different Antidepressants With Dietary Supplements |
|
|
| Completed | N/A | 88 | RoW | L-methylfolate, 5-methyl-terahydrofolate, Vitamin B12, mecobalamin, magnesium, Mg | Riphah International University | Depression | 07/23 | 08/23 | | |
| Recruiting | N/A | 1000 | | Antidepressants (fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, esitalopram, venlafaxine) ;None | West China Hospital, Sichuan University ; West China Hospital of Sichuan University, National Natural Science Foundation of China | depression | | | | |
NCT03511118: Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants |
|
|
| Recruiting | N/A | 1600 | Canada, US | Tranexamic acid (TXA), labetalol, metformin, nifedipine, clindamycin, oxycodone, azithromycin, escitalopram, sertraline, ondansetron, Ciprofloxacin, Doxycycline, Levofloxacin, Methylphenidate, Sumatriptan, Citalopram, Cyclobenzaprine, Furosemide, Gabapentin, Hydrochlorothiazide, Hydroxyurea, Rosuvastatin, Topiramate, Trazodone, Valganciclovir, Venlafaxine, Verapamil, Remdesivir, Anakinra, Tocilizumab, Fluvoxamine, Amoxicillin, Bupropion, Duloxetine, Hydrocodone, Levetiracetam, Paroxetine, Buprenorphine | Duke University, The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI | 09/24 | 09/24 | | |
NCT05830279: Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer |
|
|
| Recruiting | N/A | 600 | Canada | Pharmacogenetic testing, Drug-Drug interaction analysis | Lawson Health Research Institute | Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive, Cancer Pain | 04/25 | 04/25 | | |
OPTION-VMS, NCT06049797: A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats |
|
|
| Recruiting | N/A | 1000 | US | Fezolinetant, ESN364, VEOZAH, Paroxetine, Citalopram, Escitalopram, Desvenlafaxine, Venlafaxine, Gabapentin, Clonidine, Pregabalin, Oxybutynin, Any other SSRI/SNRI not already specified, Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above | Astellas Pharma Global Development, Inc. | Hot Flashes | 09/25 | 09/25 | | |
NCT05777876: Early Identification of TRD and Construction and Clinical Validation of NTBS Precision Technology |
|
|
| Recruiting | N/A | 400 | RoW | non-invasive transcranial deep brain stimulation, Sham stimulation, Motor cortex stimulation, non-invasive transcranial deep brain stimulation with closed-loop | First Affiliated Hospital of Zhejiang University, Zhejiang University, Kangci Hospital of Jiaxing, Wenzhou Seventh People's Hospital, Lishui Second People's Hospital, Huzhou Third People's Hospital, Binjiang Institute of Zhejiang University, Zhejiang Newways Medical Technology Co., Ltd, Hangzhou Lingnao Technology Co., Ltd | Treatment-Resistant Depression | 12/25 | 12/25 | | |
